Migraine Disorders

"Migraine Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Descriptor ID	D008881
MeSH Number(s)	C10.228.140.546.399.750
Concept/Terms	Migraine Disorders Migraine Disorders Disorder, Migraine Disorders, Migraine Migraine Disorder Migraine Migraines Migraine Headache Headache, Migraine Headaches, Migraine Migraine Headaches Acute Confusional Migraine Acute Confusional Migraine Acute Confusional Migraines Migraine, Acute Confusional Migraines, Acute Confusional Status Migrainosus Status Migrainosus Hemicrania Migraine Hemicrania Migraine Hemicrania Migraines Migraine, Hemicrania Migraines, Hemicrania Migraine Variant Migraine Variant Migraine Variants Variant, Migraine Variants, Migraine Sick Headache Sick Headache Headache, Sick Headaches, Sick Sick Headaches Abdominal Migraine Abdominal Migraine Abdominal Migraines Migraine, Abdominal Migraines, Abdominal Cervical Migraine Syndrome Cervical Migraine Syndrome Cervical Migraine Syndromes Migraine Syndrome, Cervical Migraine Syndromes, Cervical

Below are MeSH descriptors whose meaning is more general than "Migraine Disorders".

Diseases [C]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Headache Disorders [C10.228.140.546]
Headache Disorders, Primary [C10.228.140.546.399]
Migraine Disorders [C10.228.140.546.399.750]

Below are MeSH descriptors whose meaning is related to "Migraine Disorders".

Below are MeSH descriptors whose meaning is more specific than "Migraine Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Migraine Disorders" by people in this website by year, and whether "Migraine Disorders" was a major or minor topic of these publications.

Bar chart showing 123 publications over 28 distinct years, with a maximum of 11 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1998	2	0	2
1999	4	0	4
2000	2	1	3
2001	4	0	4
2002	7	0	7
2003	1	1	2
2004	2	0	2
2005	4	0	4
2006	3	0	3
2007	5	1	6
2008	4	0	4
2009	2	3	5
2010	4	0	4
2011	4	0	4
2012	2	0	2
2013	4	2	6
2014	5	0	5
2015	4	3	7
2016	3	0	3
2017	2	0	2
2018	4	0	4
2019	6	1	7
2020	4	0	4
2021	11	0	11
2022	4	0	4
2023	8	0	8
2024	5	0	5

Below are the most recent publications written about "Migraine Disorders" by people in Profiles.

Ailani J, Gandhi P, Lalla A, Halker Singh R, McAllister P, Smith JH, Dabruzzo B, Chalermpalanupap N, Kelton K, Nahas SJ. Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine. Headache. 2024 Nov-Dec; 64(10):1253-1263.

View in: PubMed
Lipton RB, Nahas SJ, Pozo-Rosich P, Bilchik T, McAllister P, Finnegan M, Liu Y, Chalermpalanupap N, Dabruzzo B, Dodick DW. Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial. J Headache Pain. 2024 May 21; 25(1):83.

View in: PubMed
Seebadri-White C, Yuan H, Young WB, Arca KN. Advocacy Connection Team-Now educational program for headache fellows and patients/caregivers: Assessment of educational objectives. Headache. 2024 04; 64(4):374-379.

View in: PubMed
Rizzoli P, Marmura MJ, Robblee J, McVige J, Sacco S, Nahas SJ, Ailani J, De Abreu Ferreira R, Ma J, Smith JH, Dabruzzo B, Ashina M. Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials. J Headache Pain. 2024 Mar 11; 25(1):35.

View in: PubMed
Tassorelli C, Onishchenko K, Halker Singh RB, Duan M, Dupont-Benjamin L, Hemstock M, Voller C, McAllister P, Nahas SJ, Gandhi P, Ailani J. Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis. Cephalalgia. 2024 02; 44(2):3331024241235156.

View in: PubMed
Szperka CL, Witzman S, Ostapenko S, Farrar JT, Hsu JY, Malavolta CP, Bunney JD, Bange EM, Patterson Gentile C, Velasquez G, Marquez de Prado B, Cosico M, Lee M, Pojomovsky McDonnell P, Prelack MS, Chadehumbe MA, Stephenson DJ, Kichula EA, Tomaine SC, Hershey AD. Patient headache questionnaires can improve headache diagnosis and treatment in children. Headache. 2023 Nov-Dec; 63(10):1359-1371.

View in: PubMed
Lipton RB, Buse DC, Nahas SJ, Tietjen GE, Martin VT, L?f E, Brevig T, Cady R, Diener HC. Risk factors for migraine disease progression: a narrative review for a patient-centered approach. J Neurol. 2023 Dec; 270(12):5692-5710.

View in: PubMed
Charleston L, Talon B, Sullivan C, Anderson C, Kymes S, Regnier SA, Soni-Brahmbhatt S, Nahas SJ. Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study. J Headache Pain. 2023 Aug 02; 24(1):101.

View in: PubMed
Amatrudo G, Kengetter J, McCrea S, Amatrudo M. Cognitive Behavioral Therapy for the Management of Episodic Migraine. Curr Pain Headache Rep. 2023 Sep; 27(9):471-477.

View in: PubMed
Yuan H, Natekar A, Park J, Lauritsen CG, Viscusi ER, Marmura MJ. Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis. Reg Anesth Pain Med. 2023 12; 48(12):581-587.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement